Alessandra Molla

An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (Ctl)-Defined, Melanocyte-Specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-Specific Ctls but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions

Andrea Anichini, Alessandra Molla, Roberta Mortarini et al. · The Journal of Experimental Medicine · 1999 · 191 citations · Full text

Life Sciences, Immunology, Oncology +17

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Roberta Mortarini, Adriano Piris, Andrea Maurichi et al. · PubMed · 2003 · 178 citations

Life Sciences, Immunology, Oncology +17

Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors.

Roberta Mortarini, Andrea Anichini, Massimo Di Nicola et al. · PubMed · 1997 · 105 citations

Life Sciences, Immunology, Oncology +17

Coexpression of NRASQ61R and BRAFV600E in Human Melanoma Cells Activates Senescence and Increases Susceptibility to Cell-Mediated Cytotoxicity

Carlotta Petti, Alessandra Molla, Claudia Vegetti et al. · Cancer Research · 2006 · 87 citations · Full text

Medicine, Molecular Biology, Oncology +17

Association of Antigen-Processing Machinery and HLA Antigen Phenotype of Melanoma Cells with Survival in American Joint Committee on Cancer Stage III and IV Melanoma Patients

Andrea Anichini, Roberta Mortarini, Daisuke Nonaka et al. · Cancer Research · 2006 · 60 citations · Full text

Medicine, Immunology, Oncology +17